Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: A pilot trial

Annals of Pharmacotherapy

Volumn 47, Issue 1, 2013, Pages 20-28

  Silinskie, Kevin M ^a   Kirshner, Ronald ^a   Hite, Mindee S ^a  

^a General Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; RECOMBINANT HUMAN INSULIN;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; HEART SURGERY; HUMAN; HYPOGLYCEMIA; INSULIN INFUSION; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY WEIGHT; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN, LONG-ACTING; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84872913613     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q698     Document Type: Article

References (30)

1. Liao P, DeSantis AJ, Schmeltz LR, et al. Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemia. J Diabetes Complications 2008;22:229-234.
2. DeCherney GS, Maser RE, Lemole GM, Serra AJ, McNicholas KW, Shapira N. Intravenous insulin infusion therapies for postoperative coro-nary artery bypass graft patients. Del Med J 1998;70:399-404.
3. Knapik P, Nadziakiewicz P, Urbanska E, Saucha W, Herdynska M, Zembala M. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Ann Thorac Surg 2009;87: 1859-1865.
4. Golden SH, Peart-Vigilance C, Koa WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999;22:1408-1414.
5. Guvener M, Pasaoglu I, Demircin M, Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 2002;49:531-537.
6. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003;75:1392-1399.
7. Lazar HL, McDonnell M, Chipkin S, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during cardiac surgery. Ann Thorac Surg 2009;87:663-669.
8. Furnary A P, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021.
9. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
10. Furnary A P, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67: 352-360.
11. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004;10(suppl 2):21-33.
12. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart surgery. Ann Thorac Surg 1997;63:356-361.
13. Hruska LA, Smith JM, Hendy MP, Fritz VL, McAdams S. Continuous insulin infusion reduces infectious complications in diabetics following coronary surgery. J Card Surg 2005;20:403-407.
14. D'Alessandro C, Leprince P, Golmard JL, et al. Strict glycemic control reduces EuroSCORE expected mortality in diabetic patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 2007;134:29-37.
15. Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 2006;26:1421-1432.
16. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-552.
17. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005;28:1008-1011.
18. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusion to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 2006;12:641-650.
19. Yeldandi RR, Lurie A, Baldwin D. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery. Diabetes Technol Ther 2006;8:609-616.
20. Olansky L, Sam S, Lober C, Yared JP, Hoogwerf B. Cleveland Clinic cardiovascular intensive care unit insulin conversion protocol. J Diabetes Sci Technol 2009;3:478-486.
21. Shomali ME, Herr DL, Hill PC, Pehilvanova BS, Sharretts JM, Magee MF. Conversion from intravenous insulin to subcutaneous insulin after cardiovascular surgery: transition to target study. Diabetes Technol Ther 2011;13: 121-126.
22. Aggarwal A, Rawn JD, Pendergrass ML, Garg R. Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery. Endocr Pract 2011;17:558-562.
23. Furnary A P, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006;98:557-564.
24. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basalbolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007;30:2181-2186.
25. Clement S, Braithwaite S, Magee M, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-591.
26. Umpierrez G, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011;34:246-261.
27. Hildebrant P, Birch K, Sestoft L, Volund A. Dose-dependent subcutaneous absorption of porcine, bovine, and human NPH insulins. Acta Med Scand 1984;215:69-73.
28. Gagnon-Auger M, du Souich P, Baillargeon JP, et al. Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes. Diabetes Care 2010;33:2502-2507.
29. Johansson UB, Amsburg S, Hannerz L, et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care 2005; 28:2025-2027.
30. NICE-SUGAR Study Investigators, Finfer S, Chittock D, Su S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.